stemcelltherapy.me valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Disallow: 
Crawl-delay: 10
Disallow: /cgi-bin/
Meta Tags
Title StemCell
Description Versant-backed startup launches with plans to broaden cell therapy’s reach – BioPharma StemCell Therapy --> Home Contact About Page 1 1 2 3 4 .. 10 20 .. » Versant-backed startup launches with plans to broaden cell therapy’s reach – BioPh
Keywords N/A
Server Information
WebSite stemcelltherapy faviconstemcelltherapy.me
Host IP 209.159.144.16
Location United States
Related Websites
Site Rank
More to Explore
stemcelltherapy.me Valuation
US$350,300
Last updated: 2022-06-24 07:31:18

stemcelltherapy.me has Semrush global rank of 30,214,984. stemcelltherapy.me has an estimated worth of US$ 350,300, based on its estimated Ads revenue. stemcelltherapy.me receives approximately 40,420 unique visitors each day. Its web server is located in United States, with IP address 209.159.144.16. According to SiteAdvisor, stemcelltherapy.me is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$350,300
Daily Ads Revenue US$324
Monthly Ads Revenue US$9,701
Yearly Ads Revenue US$116,408
Daily Unique Visitors 2,695
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
stemcelltherapy.me. A 14399 IP: 209.159.144.16
stemcelltherapy.me. NS 86400 NS Record: ns2.stemcelltherapy.me.
stemcelltherapy.me. NS 86400 NS Record: ns1.stemcelltherapy.me.
stemcelltherapy.me. MX 14400 MX Record: 0 stemcelltherapy.me.
stemcelltherapy.me. TXT 14400 TXT Record: v=spf1 +a +mx +ip4:66.45.249.130 +ip4:209.159.144.16 ~all
HtmlToTextCheckTime:2022-06-24 07:31:18
StemCell Therapy --> Home Contact About Page 1 1 2 3 4 .. 10 20 .. » Versant-backed startup launches with plans to broaden cell therapy’s reach – BioPharma Dive By daniellenierenberg Stem cell transplants can effectively cure a wide range of diseases, from blood cancers to rare genetic disorders. They’ve been used for decades and are considered standard treatment for certain conditions. But for a good number of patients, stem cell transplants are out of reach. Drug regimens used to prepare the body for a transplant are toxic and can cause serious side effects. The transplanted cells don’t always "engraft," or take root in the bone marrow. Even when they do, patients’ disease may linger or recur. A biotech startup launching Wednesday with $50 million in funding hopes that, by combining cell, antibody and gene editing technologies, at least some of these problems can be overcome. Called Cimeio Therapeutics, the new company is led by a team of pharmaceutical industry veterans and an
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sun, 24 Oct 2021 17:22:05 GMT
Server: Apache
Location: https://stemcelltherapy.me/
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 301 Moved Permanently
Date: Sun, 24 Oct 2021 17:22:05 GMT
Server: Apache
X-Powered-By: PHP/5.6.40
X-Redirect-By: WordPress
Location: https://www.stemcelltherapy.me/
Content-Type: text/html; charset=UTF-8

HTTP/1.1 200 OK
Date: Sun, 24 Oct 2021 17:22:06 GMT
Server: Apache
X-Powered-By: PHP/5.6.40
Link: ; rel="https://api.w.org/"
Content-Type: text/html; charset=UTF-8
stemcelltherapy.me Whois Information
Domain Name: STEMCELLTHERAPY.ME
Registry Domain ID: D108500000000167670-AGRS
Registrar URL: http://www.meshdigital.com
Updated Date: 2021-05-13T19:00:23Z
Creation Date: 2008-08-06T01:51:26Z
Registry Expiry Date: 2022-08-06T01:51:26Z
Registrar: Mesh Digital Limited
Registrar IANA ID: 1390
Domain Status: ok https://icann.org/epp#ok
Registrant Organization: Identity Protect Limited
Registrant State/Province: Middlesex
Registrant Country: GB
Name Server: NS1.STEMCELLTHERAPY.ME
Name Server: NS2.STEMCELLTHERAPY.ME
DNSSEC: unsigned
>>> Last update of WHOIS database: 2021-09-12T23:49:16Z <<<